These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 3553166)

  • 41. S-adenosyl-L-methionine in the treatment of Alzheimer's disease.
    Cohen BM; Satlin A; Zubenko GS
    J Clin Psychopharmacol; 1988 Feb; 8(1):43-7. PubMed ID: 3350998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overview of depression and psychosis in Alzheimer's disease.
    Wragg RE; Jeste DV
    Am J Psychiatry; 1989 May; 146(5):577-87. PubMed ID: 2653053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease.
    Tariot PN; Mack JL; Patterson MB; Edland SD; Weiner MF; Fillenbaum G; Blazina L; Teri L; Rubin E; Mortimer JA
    Am J Psychiatry; 1995 Sep; 152(9):1349-57. PubMed ID: 7653692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new rating scale for Alzheimer's disease.
    Rosen WG; Mohs RC; Davis KL
    Am J Psychiatry; 1984 Nov; 141(11):1356-64. PubMed ID: 6496779
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The evaluation of behavioral disturbances in Alzheimer's disease: the utility of three rating scales.
    Mack JL; Patterson MB
    J Geriatr Psychiatry Neurol; 1994; 7(2):99-115. PubMed ID: 8204195
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of psychiatric hospitalization on behavioral complications of Alzheimer's disease.
    Zubenko GS; Rosen J; Sweet RA; Mulsant BH; Rifai AH
    Am J Psychiatry; 1992 Nov; 149(11):1484-91. PubMed ID: 1357991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disruptive behavior and actigraphic measures in home-dwelling patients with Alzheimer's disease: preliminary report.
    Friedman L; Kraemer HC; Zarcone V; Sage S; Wicks D; Bliwise DL; Sheikh J; Tinklenberg J; Yesavage JA
    J Geriatr Psychiatry Neurol; 1997 Apr; 10(2):58-62. PubMed ID: 9188020
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selected psychiatric symptoms associated with rate of cognitive decline in patients with Alzheimer's disease.
    Miller TP; Tinklenberg JR; Brooks JO; Fenn HH; Yesavage JA
    J Geriatr Psychiatry Neurol; 1993; 6(4):235-8. PubMed ID: 8251053
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Delusions and hallucinations in an adult day care population. A longitudinal study.
    Cohen-Mansfield J; Taylor L; Werner P
    Am J Geriatr Psychiatry; 1998; 6(2):104-21. PubMed ID: 9581206
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Behavioral and psychological symptoms in Taiwanese patients with Alzheimer's disease.
    Liu CY; Wang PN; Lin KN; Liu HC
    Int Psychogeriatr; 2007 Jun; 19(3):605-13. PubMed ID: 17367555
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of music therapy on reducing agitation in patients with Alzheimer's disease, a pre-post study.
    Zare M; Ebrahimi AA; Birashk B
    Int J Geriatr Psychiatry; 2010 Dec; 25(12):1309-10. PubMed ID: 21086543
    [No Abstract]   [Full Text] [Related]  

  • 52. Dimensional versus nosographic approach to Alzheimer's disease: therapeutic implications.
    Derouesné C; Jouvent R
    Neuroepidemiology; 1990; 9(4):177-82. PubMed ID: 2215841
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of chlormethiazole and thioridazine in agitated confusional states of the elderly.
    Ather SA; Shaw SH; Stoker MJ
    Acta Psychiatr Scand Suppl; 1986; 329():81-91. PubMed ID: 3529834
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estimating the prevalence of agitation in community-dwelling persons with Alzheimer's disease.
    Tractenberg RE; Weiner MF; Thal LJ
    J Neuropsychiatry Clin Neurosci; 2002; 14(1):11-8. PubMed ID: 11884649
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The course of psychopathologic features in mild to moderate Alzheimer disease.
    Devanand DP; Jacobs DM; Tang MX; Del Castillo-Castaneda C; Sano M; Marder K; Bell K; Bylsma FW; Brandt J; Albert M; Stern Y
    Arch Gen Psychiatry; 1997 Mar; 54(3):257-63. PubMed ID: 9075466
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Delusions in dementia: a review.
    Flint AJ
    J Neuropsychiatry Clin Neurosci; 1991; 3(2):121-30. PubMed ID: 1687962
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychiatric symptoms associated with Alzheimer's disease.
    Mendez MF; Martin RJ; Smyth KA; Whitehouse PJ
    J Neuropsychiatry Clin Neurosci; 1990; 2(1):28-33. PubMed ID: 2136060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of anticholinergic activity in serum on clinical symptoms of Alzheimer's disease.
    Hori K; Konishi K; Watanabe K; Uchida H; Tsuboi T; Moriyasu M; Tominaga I; Hachisu M
    Neuropsychobiology; 2011; 63(3):147-53. PubMed ID: 21228606
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessing Alzheimer's disease patients with the Cohen-Mansfield Agitation Inventory: scoring and clinical implications.
    Weiner MF; Tractenberg RE; Jin S; Gamst A; Thomas RG; Koss E; Thal LJ
    J Psychiatr Res; 2002; 36(1):19-25. PubMed ID: 11755457
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new scale for assessing behavioral agitation in dementia.
    Sinha D; Zemlan FP; Nelson S; Bienenfeld D; Thienhaus O; Ramaswamy G; Hamilton S
    Psychiatry Res; 1992 Jan; 41(1):73-88. PubMed ID: 1561290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.